![Together with Sanofi, Agro-Bio presented poster about antibody tool development for pharmacokinetic tests](/sites/stago_agrobio/files/2022-12/Icone-polyclonal-and-monoclonal-antibodies-development-sensitive-pharmacokinetic-assay-in-phase-I-of-therapeutic-monoclonal-antibody_04.jpg)
28/11/18
Agro-Bio took the opportunity of the last EBF congress to communicate about one of its collaborations with Sanofi research team.
Lionel Cambrils - Manager Sales - with a Sanofi researcher spoke about our works. They presented a poster during the poster session on last Friday morning (11/23/2018) of EBF congress in Barcelona.For this phase-I clinical project, Agro-Bio offered its expertise on anti-idiotypic antibody development. The aim was to develop antibodies (monoclonal and polyclonal) to set up a sensitive (pg/mL) pharmacocinetic test for a potential therapeutic moleclule.